Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA: a Multicenter, Randomized, Controlled, Phase III Clinical Trial.

NCT05797077 is registered in ClinicalTrials.gov with Sixth Affiliated Hospital, Sun Yat-sen University as lead sponsor.

NCT NCT05797077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05797077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA: a Multicenter, Randomized, Controlled, Phase III Clinical Trial.
Lead sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Phase
Phase 3
Overall status
Recruiting
Start date
February 20, 2023
Completion date
February 20, 2031
Enrollment
346 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, therapy-related, circulating tumor cell, colorectal cancer, liver metastases